REG - MavIncGroVCT4 - Net Asset Value(s)

Maven Income and Growth VCT 4Announcement

09/05/2025 10:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250509:nRSI0786Ia&default-theme=true

RNS Number : 0786I  Maven Income & Growth VCT 4 PLC  09 May 2025

Maven Income and Growth VCT 4 PLC

 

 

Unaudited Net Asset Value

 

The Directors confirm:

 

•      Unaudited net asset value (NAV)(1) of 58.85p per Ordinary Share
as at 31 March 2025, compared to 59.47p at

       31 December 2024; and

 

•      NAV total return(2) of 153.70p per Ordinary Share as at 31 March
2025, compared to 154.32p at 31 December 2024

 

Notes:

(1)The NAV at 31 March 2025 is unaudited and reflects the closing bid price of
quoted securities as at that date. Investments in unlisted companies are
normally valued on a six-monthly basis and the NAV incorporates the Directors'
valuation of unlisted investments as at 31 December 2024, adjusted for
subsequent events where appropriate. There have been no material changes in
the valuations of any of the unlisted investments during the period from 31
December 2024 to the date of this announcement.

(2)NAV total return is the sum of NAV per Ordinary Share and dividends paid
per Ordinary Share since launch.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

9 May 2025

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NAVUKRKRVUUVRRR